Introduction
Millions of Americans rely on medications to manage chronic back pain, arthritis, and muscle spasms. But a large new study is raising concerns about a common group of drugs that may affect more than just pain relief.
Researchers have found that long-term use of certain anticholinergic medications—often prescribed for back pain and muscle relaxation—may be linked to a higher risk of developing dementia, including Alzheimer’s disease.
While the research does not prove that these medications directly cause dementia, experts say the findings are serious enough that patients and doctors should carefully review long-term use, especially among older adults.
Understanding the potential risks can help people make safer decisions about pain management while protecting long-term brain health.
Why This Study Matters
Back pain is one of the most common medical complaints in the United States. As a result, medications that relax muscles or reduce nerve activity are prescribed frequently.
